Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.

MLA

Bergeron, Anne, et al. “Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.” JAMA: Journal of the American Medical Association, vol. 318, no. 6, Aug. 2017, pp. 557–66. EBSCOhost, https://doi.org/10.1001/jama.2017.9938.

APA

Bergeron, A., Chevret, S., Granata, A., Chevallier, P., Vincent, L., Anne Huynh, Tabrizi, R., Labussiere-Wallet, H., Bernard, M., Chantepie, S., Bay, J.-O., Thiebaut-Bertrand, A., Thepot, S., Contentin, N., Fornecker, L.-M., Maillard, N., Risso, K., Berceanu, A., Blaise, D., & Peffault de La Tour, R. (2017). Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial. JAMA: Journal of the American Medical Association, 318(6), 557–566. https://doi.org/10.1001/jama.2017.9938

Chicago

Bergeron, Anne, Sylvie Chevret, Angela Granata, Patrice Chevallier, Laure Vincent, Anne Huynh, Reza Tabrizi, et al. 2017. “Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.” JAMA: Journal of the American Medical Association 318 (6): 557–66. doi:10.1001/jama.2017.9938.